
Intrasense
ALINS | PA
Overview
Corporate Details
- ISIN(s):
- FR0011179886 (+2 more)
- LEI:
- 969500VF6MOVQXWHAE33
- Country:
- France
- Address:
- 1231 AVENUE DU MONDIAL 98, 34000 MONTPELLIER
- Website:
- https://www.intrasense.fr/
- Sector:
- Publishing, broadcasting, and content production and distribution activities
- Industry:
- Software publishing
Description
Intrasense, a subsidiary of the Guerbet Group founded in 2004, is a medical technology company that develops and markets AI-enhanced software solutions for medical imaging. The company's platforms are designed to facilitate and secure diagnosis, decision-making, and therapeutic follow-up for medical professionals, particularly radiologists. Its core product portfolio includes Myrian®, an advanced visualization platform, and Liflow®, a solution dedicated to oncology imaging. Intrasense focuses on natively integrating artificial intelligence tools directly into the clinical workflow to improve diagnostic precision and efficiency. The company's solutions, including the DUOnco™ suite of AI algorithms for oncology, serve a global client base.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Intrasense.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-08-13 18:00 |
Regulatory News Service
INTRASENSE : Certification CE de DUOnco™ Pancreas : une innovation clé pour la …
|
French | 263.7 KB | |
2025-06-06 15:15 |
Earnings Release
Activity Update: structured offering of AI Solutions in oncological imaging and…
|
English | 289.2 KB | |
2025-06-06 15:00 |
Earnings Release
Point d’activité : offre structurée des solutions d’IA en imagerie oncologique …
|
French | 319.6 KB | |
2025-05-23 18:00 |
Board/Management Information
Evolution de la composition du Conseil d’administration d’Intrasense
|
French | 668.2 KB | |
2025-05-23 18:00 |
Board/Management Information
Change in the Composition of the Intrasense Board of Directors
|
English | 668.3 KB | |
2025-05-23 18:00 |
Board/Management Information
Annule et remplace : Change in the Composition of the Intrasense Board of Direc…
|
English | 668.1 KB | |
2025-03-26 18:00 |
Investor Presentation
Des résultats annuels 2024 en retrait dans un contexte assumé de transformation…
|
French | 730.9 KB | |
2025-03-26 18:00 |
Earnings Release
Full-year results for 2024 down against a backdrop of transformation, product r…
|
English | 750.1 KB | |
2025-03-18 17:45 |
Legal Proceedings Report
DUOnco TM Bone : premier algorithme d’IA marqué CE pour la détection automatiqu…
|
French | 700.9 KB | |
2025-03-18 17:45 |
Legal Proceedings Report
DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone le…
|
English | 636.4 KB | |
2025-02-24 17:45 |
Report Publication Announcement
RECTIFICATIF - Agenda financier 2025
|
French | 225.6 KB | |
2025-02-12 17:45 |
Investor Presentation
Présentation de la solution Liflow® lors de l’événement AI Action Summit à Par…
|
French | 302.7 KB | |
2024-12-16 17:45 |
Regulatory News Service
Intrasense announces the CE marking of Liflow®’s new version enhanced by AI ded…
|
French | 637.0 KB | |
2024-12-03 17:45 |
Regulatory News Service
Communiqué de presse 1/5 Guerbet, Intrasense, Gustave Roussy et le CHU d’Angers…
|
French | 813.8 KB | |
2024-11-06 17:45 |
Report Publication Announcement
Intrasense annonce sa participation au RSNA 2024, congrès de référence mondiale…
|
French | 617.0 KB |
Automate Your Workflow. Get a real-time feed of all Intrasense filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Intrasense via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |